Is the ornithine transcarbamylase gene a genetic determinant of Alzheimer’s disease?
| Autor: | Dominique Campion, Philippe Amouyel, Didier Hannequin, Anne Marie Ayral, Jean-Charles Lambert, Florence Pasquier, Elio Scarpini, Franck Hansmannel, Daniela Galimberti, Geoffroy Laumet, Julien Chapuis, Corinne Lendon, Julie Dumont |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
Male
Apolipoprotein E Genotype International Cooperation Population Ornithine transcarbamylase Single-nucleotide polymorphism Biology Polymorphism Single Nucleotide Apolipoproteins E Sex Factors Gene Frequency Alzheimer Disease Odds Ratio medicine Humans Genetic Predisposition to Disease Allele Promoter Regions Genetic education Ornithine Carbamoyltransferase Aged Genetic association Aged 80 and over Genetics education.field_of_study General Neuroscience medicine.disease United Kingdom Minor allele frequency Italy Case-Control Studies Female France Alzheimer's disease |
| Zdroj: | Neuroscience Letters. 449:76-80 |
| ISSN: | 0304-3940 |
| DOI: | 10.1016/j.neulet.2008.10.081 |
| Popis: | Expression of ornithine transcarbamylase (OTC) is strongly induced in the brain of individuals suffering from Alzheimer’s Disease (AD). Association studies in a population from northern France have revealed that two SNPs −389 G/A (rs5963409) and −241 A/G (rs5963411) located in the promoter of the OTC gene are associated with the risk of developing AD. In the present work, these association studies were extended to a population of 2113 AD cases and 1580 controls from northern France, western France, the United Kingdom and Italy. The rs5963409 minor allele was weakly but significantly associated with an increased risk of developing AD (OR = 1.19, p = 0.004). This association was independent of age and ApoE status. Our results support that the OTC gene may be a minor genetic determinant of AD. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect